ProCE Banner Activity


Updates in the Management of Psoriatic Arthritis

PCE On Demand Live Presentation

Psoriatic arthritis (PsA) is a complex, chronic inflammatory musculoskeletal disease. Due to its progressive and destructive nature, PsA has a significant impact on quality of life. It is imperative for healthcare professionals to accurately identify and treat the condition quickly; however, nearly 50% of patients do not receive a diagnosis until 2 years after their symptom onset. New insights into PsA pathophysiology have led to a rapidly expanding treatment armamentarium, including agents that can improve symptoms and decrease disease-related destruction. Join us for this on-demand webcast as experts in PsA discuss available therapeutic guidelines, recent literature, and best practices to individualize treatment plans for improved patient outcomes.

In collaboration with the Society of Physician Assistants in Rheumatology

Physician Assistants/Physician Associates: 1.00 AAPA Category 1 CME credit

Nurse Practitioners: 1.00 Nursing contact hours, includes 1.00 hour of pharmacotherapy credit

Released: October 20, 2022

Expiration: October 19, 2023

No longer available for credit.



Shannon Ghizzoni

Shannon Ghizzoni, PA-C

Physician Assistant
Columbus Arthritis Center
Columbus, Ohio

Elaine Husni

Elaine Husni, MD, MPH

Vice Chair
Staff Rheumatologist
Department of Rheumatic and Immunologic Diseases
Cleveland Clinic
Cleveland, Ohio

Joan McTigue

Joan McTigue, MS, PA-C

Physician Assistant
Division of Rheumatology
University of Florida College of Medicine
Gainesville, Florida


This activity is supported by an educational grant from Janssen Biotech, Inc. administered by Janssen Scientific Affairs, LLC.

Provided by

ProCE Banner


Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC

Target Audience

NPs and PAs specializing in rheumatology

Learning Objectives

Upon completion of this activity, participants should be able to:

  • Identify appropriate uses of new and emerging agents for patients with PsA

  • Create treatment plans for patients with PsA based on current guidelines, patient disease course, and patient preferences

  • Apply up-to-date methods for assessment and management of comorbidities and dermatologic manifestations of psoriatic disease


All faculty and planners participating in continuing education activities sponsored by Partners for Advancing Clinical Education (PACE) are required to disclose all financial relationships with ineligible companies. All relevant conflicts of interest are thoroughly vetted and mitigated according to PCE policy. In addition, all faculty are required to openly disclose any off-label, experimental, or investigational use of drugs or devices discussed in this activity. The faculty and Planning Committee have been advised that this activity must be free from commercial bias and based upon all available scientifically rigorous data from research that conforms to accepted standards of experimental design, data collection, and analysis.

Shannon Ghizzoni, PA-C: consultant/advisor/speaker: AbbVie, Amgen, Novartis.

Elaine Husni, MD, MPH: consultant/advisor/speaker: AbbVie, Amgen, Bristol-Myers Squibb, Janssen, Lilly, Novartis, Pfizer, UCB.

Joan McTigue, MS, PA-C, has no relevant financial relationships to disclose.

Jennifer Simpson, DNP: consultant/advisor/speaker: AbbVie, Amgen, AstraZeneca, Horizon, Janssen.

None of the members of the Planning Committee, PACE or PCE staff have any relevant financial relationships to disclose, except Jennifer Simpson, DNP, as noted above.

Instructions for Credit

Learners wishing to earn CE/CME credit must:

  1. View the content in its entirety
  2. Relate the content material to the learning objectives
  3. Complete evaluation form

The estimated time to complete this activity is 1.00 hour.

Release date: October 20, 2022
Expiration date: October 19, 2023


On-demand webcast


The opinions or views expressed in this CE/CME activity do not necessarily reflect the opinions or recommendations of Practicing Clinicians Exchange, Partners for Advancing Clinical Education, or any educational supporter.


Joint Accreditation Statement

Joint AccreditationIn support of improving patient care, Partners for Advancing Clinical Education (PACE) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

ANCC Credit Designation

NP course advisor: Jennifer Simpson, DNP, Arizona Arthritis and Rheumatology Associates, Phoenix, Arizona
Nursing contact hours: 1.00, which includes 1.00 hour of pharmacology credit

AAPA Credit Designation

Joint AccreditationPartners for Advancing Clinical Education (PACE) has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.00 AAPA Category 1 CME credit. Approval is valid until October 19, 2023. PAs should only claim credit commensurate with the extent of their participation.

IPCE Credit Designation
IPCEThis activity was planned by and for the healthcare team, and learners will receive 1.00 Interprofessional Continuing Education (IPCE) credit for learning and change.

Additional Information

Program Medium

This program has been made available online.